Trial Profile
Multiple ascending dose study of the ABCA1 inducer RG 7273.
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 08 Nov 2011
Price :
$35
*
At a glance
- Drugs RG 7273 (Primary)
- Indications Dyslipidaemias
- Focus Adverse reactions
- 08 Nov 2011 New trial record